Terms: = Thyroid cancer AND PTCH1, RP11-435O5_3, Q13635, PTCH, 5727, HPE7, FLJ26746, NBCCS, BCNS, PTC1, ENSG00000185920, FLJ42602
279 results:
1. Alterations in the amino acid profile in patients with papillary thyroid carcinoma with and without Hashimoto's thyroiditis.
Hellmann A; Turyn J; Zwara A; Korczynska J; Taciak A; Mika A
Front Endocrinol (Lausanne); 2023; 14():1199291. PubMed ID: 37664829
[TBL] [Abstract] [Full Text] [Related]
2. Evaluating the Correlation of Hedgehog Pathway with Claudin-1 Expression in Invasive Breast cancer.
Chen D; Cheng X
Cell Mol Biol (Noisy-le-grand); 2023 Feb; 69(2):60-66. PubMed ID: 37224045
[TBL] [Abstract] [Full Text] [Related]
3. Effects of miR-145 targeting rab5c and regulating MAPK / ERK signaling pathway on proliferation and invasion of thyroid papillary carcinoma cells.
Wen X; Yan Z; Du J; Dai J; Liu M; Wang X; Wang N
Cell Mol Biol (Noisy-le-grand); 2023 Jan; 69(1):44-47. PubMed ID: 37213158
[TBL] [Abstract] [Full Text] [Related]
4. [Clinical significance of multigene assay in papillary thyroid carcinoma].
Shi Y; Qian K; Guo K; Liu J; Wang Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 May; 37(5):375-379. PubMed ID: 37138401
[No Abstract] [Full Text] [Related]
5. Molecular Genetics of Diffuse Sclerosing Papillary thyroid cancer.
Alswailem M; Alghamdi B; Alotaibi A; Aljomiah A; Al-Hindi H; Murugan AK; Abouelhoda M; Shi Y; Alzahrani AS
J Clin Endocrinol Metab; 2023 Aug; 108(9):e704-e711. PubMed ID: 36995892
[TBL] [Abstract] [Full Text] [Related]
6. Detection of driver mutations in plasma cell-free nucleic acids in differentiated thyroid neoplasm.
Dutta S; Tarafdar S; Mukhopadhyay P; Bhattacharyya NP; Ghosh S
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36744987
[TBL] [Abstract] [Full Text] [Related]
7. Adversary of DNA integrity: A long non-coding RNA stimulates driver oncogenic chromosomal rearrangement in human thyroid cells.
Demin DE; Murashko MM; Uvarova AN; Stasevich EM; Shyrokova EY; Gorlachev GE; Zaretsky AR; Korneev KV; Ustiugova AS; Tkachenko EA; Kostenko VV; Tatosyan KA; Sheetikov SA; Spirin PV; Kuprash DV; Schwartz AM
Int J Cancer; 2023 Apr; 152(7):1452-1462. PubMed ID: 36510744
[TBL] [Abstract] [Full Text] [Related]
8. Molecular mechanism of extracutaneous tumours in patients with basal cell nevus syndrome.
Verkouteren BJ; Roemen GM; Schuurs-Hoeijmakers JH; Abdul Hamid M; van Geel M; Speel EM; Mosterd K
J Clin Pathol; 2023 May; 76(5):345-348. PubMed ID: 36002246
[TBL] [Abstract] [Full Text] [Related]
9. Testing of mutations on thyroid nodules with indeterminate cytology: A prospective study of 112 patients in Argentina.
Tolaba N; Spedalletti Y; Bazzoni P; Galindez M; Cerioni V; Santillan C; Richter G; Herrera C; Sanchez L; Van Cawulaert L; Toscano MA; Nallar M; Monteros Alvi M; Moya CM
Endocrinol Diabetes Nutr (Engl Ed); 2022 Feb; 69(2):122-130. PubMed ID: 35256055
[TBL] [Abstract] [Full Text] [Related]
10. Molecular profiling of papillary thyroid carcinomas in healthcare workers exposed to low dose radiation at the workplace.
Duque CS; Vélez A; Cuartas J; Jaimes F; Dueñas JP; Agudelo M; Nikiforova MN; Nikiforov YE; Condello V
Endocrine; 2022 Apr; 76(1):95-100. PubMed ID: 35094311
[TBL] [Abstract] [Full Text] [Related]
11. cancer-Predisposition Genetic Analysis in Children with Brain Tumors Treated at a Single Institution in Japan.
Fukushima H; Suzuki R; Yamaki Y; Hosaka S; Inaba M; Muroi A; Tsurubuchi T; Morii W; Noguchi E; Takada H
Oncology; 2022; 100(3):163-172. PubMed ID: 34959239
[TBL] [Abstract] [Full Text] [Related]
12. Combination of ultrasound and molecular testing in malignancy risk estimate of Bethesda category IV thyroid nodules: results from a single-institution prospective study.
Marina M; Zatelli MC; Goldoni M; Del Rio P; Corcione L; Martorana D; Percesepe A; Bonatti F; Mozzoni P; Crociara A; Ceresini G
J Endocrinol Invest; 2021 Dec; 44(12):2635-2643. PubMed ID: 33860907
[TBL] [Abstract] [Full Text] [Related]
13. Atypical de Quervain's thyroiditis diagnosed as atypia of undetermined significance by cytology and suspicious for cancer by Afirma Genomic Sequencing Classifier.
Yu R; Yang SE; Rao J
Diagn Cytopathol; 2021 Aug; 49(8):E312-E315. PubMed ID: 33656790
[TBL] [Abstract] [Full Text] [Related]
14. Germ Line Mutations in the thyroid Hormone Receptor Alpha Gene Predispose to Cutaneous Tags and Melanocytic Nevi.
Di Cicco E; Moran C; Visser WE; Nappi A; Schoenmakers E; Todd P; Lyons G; Dattani M; Ambrosio R; Parisi S; Salvatore D; Chatterjee K; Dentice M
Thyroid; 2021 Jul; 31(7):1114-1126. PubMed ID: 33509032
[No Abstract] [Full Text] [Related]
15. Association between functional polymorphisms in the flanking region of miR-143/145 and risk of papillary thyroid carcinoma: A case-control study.
Wang Y; Zhou S; Zhao W; Li Z; Zhu J; Wei T; Song H
Medicine (Baltimore); 2020 Dec; 99(49):e23560. PubMed ID: 33285775
[TBL] [Abstract] [Full Text] [Related]
16. The Clinicopathological Results of thyroid cancer With BRAFV600E Mutation in the Young Population of Fukushima.
Iwadate M; Mitsutake N; Matsuse M; Fukushima T; Suzuki S; Matsumoto Y; Ookouchi C; Mizunuma H; Nakamura I; Nakano K; Sakamoto A; Hirokawa M; Ito M; Naganuma H; Hashimoto Y; Shimura H; Yamashita S; Suzuki S
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32827026
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
Chu YH; Wirth LJ; Farahani AA; Nosé V; Faquin WC; Dias-Santagata D; Sadow PM
Mod Pathol; 2020 Dec; 33(12):2458-2472. PubMed ID: 32737449
[TBL] [Abstract] [Full Text] [Related]
18. Genetic Alterations in Pediatric thyroid cancer Using a Comprehensive Childhood cancer Gene Panel.
Alzahrani AS; Alswailem M; Alswailem AA; Al-Hindi H; Goljan E; Alsudairy N; Abouelhoda M
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556222
[TBL] [Abstract] [Full Text] [Related]
19. Molecular mutations as a possible factor for determining extent of thyroid surgery.
Krasner JR; Alyouha N; Pusztaszeri M; Forest VI; Hier MP; Avior G; Payne RJ
J Otolaryngol Head Neck Surg; 2019 Oct; 48(1):51. PubMed ID: 31623671
[TBL] [Abstract] [Full Text] [Related]
20. Silencing NEAT1 suppresses thyroid carcinoma via miR-126/NEAT1/VEGFA axis.
Zeng W; Lin Y; Lin H; Wu X
Front Biosci (Landmark Ed); 2020 Jan; 25(3):564-576. PubMed ID: 31585904
[TBL] [Abstract] [Full Text] [Related]
[Next]
